BR9810055A - Réplicons de vìrus epstein-barr compacto - Google Patents

Réplicons de vìrus epstein-barr compacto

Info

Publication number
BR9810055A
BR9810055A BR9810055-6A BR9810055A BR9810055A BR 9810055 A BR9810055 A BR 9810055A BR 9810055 A BR9810055 A BR 9810055A BR 9810055 A BR9810055 A BR 9810055A
Authority
BR
Brazil
Prior art keywords
replicons
compact
epstein
barr viruses
nucleic acid
Prior art date
Application number
BR9810055-6A
Other languages
English (en)
Inventor
Brian Seed
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of BR9810055A publication Critical patent/BR9810055A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"RéPLICONS DE VìRUS EPSTEIN-BARR COMPACTO"<D>. São divulgadas neste caso, seq³ências de ácido nucléico que apóiam a replicação epissomal em uma célula de mamífero. Estas seq³ências de ácido nucléico, que têm um comprimento de menos de 3 kb, incluem(a) uma seq³ência de OriP retirada e (b) uma seq³ência de EBNA1 retirada operavelmente ligada a um promotor.
BR9810055-6A 1997-06-19 1998-04-14 Réplicons de vìrus epstein-barr compacto BR9810055A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5020697P 1997-06-19 1997-06-19
PCT/US1998/007641 WO1998057658A1 (en) 1997-06-19 1998-04-14 Compact epstein-barr virus replicons

Publications (1)

Publication Number Publication Date
BR9810055A true BR9810055A (pt) 2000-09-12

Family

ID=21963948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810055-6A BR9810055A (pt) 1997-06-19 1998-04-14 Réplicons de vìrus epstein-barr compacto

Country Status (20)

Country Link
US (1) US6133025A (pt)
EP (1) EP1032418B1 (pt)
JP (1) JP2002505586A (pt)
KR (1) KR100569826B1 (pt)
CN (1) CN1263861C (pt)
AR (1) AR054291A1 (pt)
AT (1) ATE270341T1 (pt)
AU (1) AU744680B2 (pt)
BR (1) BR9810055A (pt)
CA (1) CA2293299A1 (pt)
DE (1) DE69824881T2 (pt)
DK (1) DK1032418T3 (pt)
ES (1) ES2224382T3 (pt)
HU (1) HUP0003971A3 (pt)
ID (1) ID24649A (pt)
PL (1) PL337528A1 (pt)
PT (1) PT1032418E (pt)
RU (1) RU2240348C2 (pt)
TR (1) TR199903155T2 (pt)
WO (1) WO1998057658A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090533A2 (en) * 2001-05-07 2002-11-14 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
DK2631297T3 (en) 2008-05-15 2017-08-07 Nat Res Council Canada PROCEDURE, VECTORS AND MANIPULATED CELL LINES TO IMPROVE LARGE SCALE TRANSFECTION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939088A (en) * 1987-02-18 1990-07-03 Meloy Laboratories Inc. Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon

Also Published As

Publication number Publication date
RU2240348C2 (ru) 2004-11-20
CN1263861C (zh) 2006-07-12
ES2224382T3 (es) 2005-03-01
HUP0003971A2 (en) 2001-03-28
EP1032418A1 (en) 2000-09-06
KR100569826B1 (ko) 2006-04-11
TR199903155T2 (en) 2000-09-21
EP1032418A4 (en) 2002-01-02
KR20010013901A (ko) 2001-02-26
WO1998057658A1 (en) 1998-12-23
ATE270341T1 (de) 2004-07-15
AU744680B2 (en) 2002-02-28
JP2002505586A (ja) 2002-02-19
CA2293299A1 (en) 1998-12-23
AR054291A1 (es) 2007-06-20
CN1278185A (zh) 2000-12-27
AU7123998A (en) 1999-01-04
EP1032418B1 (en) 2004-06-30
DE69824881T2 (de) 2004-11-18
DK1032418T3 (da) 2004-11-01
US6133025A (en) 2000-10-17
PT1032418E (pt) 2004-10-29
PL337528A1 (en) 2000-08-28
DE69824881D1 (de) 2004-08-05
HUP0003971A3 (en) 2003-03-28
ID24649A (id) 2000-07-27

Similar Documents

Publication Publication Date Title
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
BR9908015A (pt) Composições que compreendem vìrus e métodos para concentração de preparações de vìrus
DK0387775T3 (da) Genetisk enhed til inhibering af funktionen af RNA
PT100472A (pt) Sequencias genomicas do virus da hepatite c e composicoes farmaceuticas que as contem, para diagnostico e terapeutica da hepatite c
DK0597960T3 (da) Behandling af cellepopulationer
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DK0907735T5 (da) Modulatorer af vævsregenerering
BR0011033A (pt) Métodos de purificação de dna e dna purificado
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
KR950700298A (ko) 뉴클레오시드 치료제(Therapeutic Nucleosides)
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DK0592836T3 (da) DNA af integrationsstedet for humant adenoassocieret virus og dets anvendelse
FR2717498B1 (fr) Transcrits du gène de CMH de classe I HLA-G et leurs applications.
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
DE69433978D1 (de) Methode der spezifischen abschaltung von genen durch dna-methylierung
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
PT1298208E (pt) Ribozimas que abordam selectivamente uma sequencia tat do hiv
BR9810055A (pt) Réplicons de vìrus epstein-barr compacto
DE59209773D1 (de) Equine Herpesviren (EHV), die Fremd-DNA enthalten, Verfahren zu ihrer Herstellung und ihre Verwendung in Impfstoffen
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
ES2196157T3 (es) Oligonucleotidos especificos para el virus de la hepatitis c.
BR9807061A (pt) Purificação de dna em uma centrìfuga de fluxo contìnuo

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time